1. Home
  2. CCCC vs IDN Comparison

CCCC vs IDN Comparison

Compare CCCC & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • IDN
  • Stock Information
  • Founded
  • CCCC 2015
  • IDN 1994
  • Country
  • CCCC United States
  • IDN United States
  • Employees
  • CCCC N/A
  • IDN N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • IDN Computer Software: Prepackaged Software
  • Sector
  • CCCC Health Care
  • IDN Technology
  • Exchange
  • CCCC Nasdaq
  • IDN Nasdaq
  • Market Cap
  • CCCC 104.4M
  • IDN 101.6M
  • IPO Year
  • CCCC 2020
  • IDN 1999
  • Fundamental
  • Price
  • CCCC $2.46
  • IDN $5.02
  • Analyst Decision
  • CCCC Buy
  • IDN Strong Buy
  • Analyst Count
  • CCCC 2
  • IDN 3
  • Target Price
  • CCCC $8.00
  • IDN $6.17
  • AVG Volume (30 Days)
  • CCCC 1.5M
  • IDN 194.3K
  • Earning Date
  • CCCC 08-07-2025
  • IDN 08-12-2025
  • Dividend Yield
  • CCCC N/A
  • IDN N/A
  • EPS Growth
  • CCCC N/A
  • IDN N/A
  • EPS
  • CCCC N/A
  • IDN N/A
  • Revenue
  • CCCC $34,240,000.00
  • IDN $20,662,000.00
  • Revenue This Year
  • CCCC N/A
  • IDN $9.35
  • Revenue Next Year
  • CCCC N/A
  • IDN $13.05
  • P/E Ratio
  • CCCC N/A
  • IDN N/A
  • Revenue Growth
  • CCCC 16.55
  • IDN 7.12
  • 52 Week Low
  • CCCC $1.09
  • IDN $1.92
  • 52 Week High
  • CCCC $7.22
  • IDN $6.49
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 59.48
  • IDN 48.83
  • Support Level
  • CCCC $1.95
  • IDN $4.88
  • Resistance Level
  • CCCC $2.94
  • IDN $5.50
  • Average True Range (ATR)
  • CCCC 0.26
  • IDN 0.28
  • MACD
  • CCCC 0.00
  • IDN -0.01
  • Stochastic Oscillator
  • CCCC 51.52
  • IDN 46.67

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

Share on Social Networks: